STING1 and cancer: Re-located STING could activate TANK-binding kinase 1 (TBK1), NF-κB, and interferon regulatory transcription factor 3 (IRF3), which then stimulate the production of IFN, an essential factor in anti-cancer immunity12, and other inflammatory cytokines10.